Literature DB >> 34686184

Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study.

Yuqi Wang1,2, Liangxu Wang3, Yanli Su4, Li Zhong4, Bin Peng5.   

Abstract

BACKGROUND: Impaired fasting glucose (IFG) is a prediabetic condition. Considering that the clinical symptoms of IFG are inconspicuous, these tend to be easily ignored by individuals, leading to conversion to diabetes mellitus (DM). In this study, we established a prediction model for the onset risk of IFG in the Chongqing health check-up population to provide a reference for prevention in a health check-up cohort.
METHODS: We conducted a retrospective longitudinal cohort study in Chongqing, China from January 2009 to December 2019. The qualified subjects were more than 20 years old and had more than two health check-ups. After following the inclusion and exclusion criteria, the cohort population was randomly divided into a training set and a test set at a ratio of 7:3. We first selected the predictor variables through the univariate generalized estimation equation (GEE), and then the training set was used to establish the IFG risk model based on multivariate GEE. Finally, the sensitivity, specificity, and receiver operating characteristic curves were used to verify the performance of the model.
RESULTS: A total of 4,926 subjects were included in this study, with an average of 3.87 check-up records, including 2,634 males and 2,292 females. There were 442 IFG cases during the follow-up period, including 286 men and 156 women. The incidence density was 26.88/1000 person-years for men and 18.53/1000 person-years for women (P<0.001). The predictor variables of our prediction model include male (relative risk (RR) =1.422, 95 % confidence interval (CI): 0.923-2.193, P=0.3849), age (RR=1.030, 95 %CI: 1.016-1.044, P<0.0001), waist circumference (RR=1.005, 95 %CI: 0.999-1.012, P=0.0975), systolic blood pressure (RR=1.004, 95 %CI: 0.993-1.016, P=0.4712), diastolic blood pressure (RR=1.023, 95 %CI: 1.005-1.041, P=0.0106), obesity (RR=1.797, 95 %CI: 1.126-2.867, P=0.0140), triglycerides (RR=1.107, 95 %CI: 0.943-1.299, P=0.2127), high-density lipoprotein cholesterol (RR=0.992, 95 %CI: 0.476-2.063, P=0.9818), low-density lipoprotein cholesterol (RR=1.793, 95 %CI: 1.085-2.963, P=0.0228), blood urea (RR=1.142, 95 %CI: 1.022-1.276, P=0.0192), serum uric acid (RR=1.004, 95 %CI: 1.002-1.005, P=0.0003), total cholesterol (RR=0.674, 95 %CI: 0.403-1.128, P=0.1331), and serum creatinine levels (RR=0.960, 95 %CI: 0.945-0.976, P<0.0001). The area under the receiver operating characteristic curve (AUC) in the training set was 0.740 (95 %CI: 0.712-0.768), and the AUC in the test set was 0.751 (95 %CI: 0.714-0.817).
CONCLUSIONS: The prediction model for the onset risk of IFG had good predictive ability in the health check-up cohort.
© 2021. The Author(s).

Entities:  

Keywords:  Health check-up cohort; Impaired fasting glucose; Prediction model

Mesh:

Year:  2021        PMID: 34686184      PMCID: PMC8540134          DOI: 10.1186/s12902-021-00878-4

Source DB:  PubMed          Journal:  BMC Endocr Disord        ISSN: 1472-6823            Impact factor:   2.763


  34 in total

1.  Diabetes Mellitus: A Local and Global Public Health Emergency!

Authors:  Jawad A Al-Lawati
Journal:  Oman Med J       Date:  2017-05

2.  Personalised medicine, disease prevention, and the inverse care law: more harm than benefit?

Authors:  Jack E James
Journal:  Eur J Epidemiol       Date:  2014-04-12       Impact factor: 8.082

Review 3.  Epidemiology in diabetes mellitus and cardiovascular disease.

Authors:  Wenjun Fan
Journal:  Cardiovasc Endocrinol       Date:  2017-02-15

4.  IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.

Authors:  N H Cho; J E Shaw; S Karuranga; Y Huang; J D da Rocha Fernandes; A W Ohlrogge; B Malanda
Journal:  Diabetes Res Clin Pract       Date:  2018-02-26       Impact factor: 5.602

Review 5.  Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment.

Authors:  Goodarz Danaei; Carlene M M Lawes; Stephen Vander Hoorn; Christopher J L Murray; Majid Ezzati
Journal:  Lancet       Date:  2006-11-11       Impact factor: 79.321

6.  A prediction model for type 2 diabetes risk among Chinese people.

Authors:  K Chien; T Cai; H Hsu; T Su; W Chang; M Chen; Y Lee; F B Hu
Journal:  Diabetologia       Date:  2008-12-05       Impact factor: 10.122

7.  Effect of insulin on uric acid excretion in humans.

Authors:  A Quiñones Galvan; A Natali; S Baldi; S Frascerra; G Sanna; D Ciociaro; E Ferrannini
Journal:  Am J Physiol       Date:  1995-01

8.  Body mass index and risk of all-cause mortality with normoglycemia, impaired fasting glucose and prevalent diabetes: results from the Rural Chinese Cohort Study.

Authors:  Yang Zhao; Yu Liu; Haohang Sun; Xizhuo Sun; Zhaoxia Yin; Honghui Li; Yongcheng Ren; Bingyuan Wang; Dongdong Zhang; Xuejiao Liu; Dechen Liu; Ruiyuan Zhang; Feiyan Liu; Xu Chen; Leilei Liu; Cheng Cheng; Qionggui Zhou; Dongsheng Hu; Ming Zhang
Journal:  J Epidemiol Community Health       Date:  2018-07-24       Impact factor: 3.710

9.  Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers.

Authors:  N Nakanishi; M Okamoto; H Yoshida; Y Matsuo; K Suzuki; K Tatara
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

10.  The Metabolic Effects of Cynara Supplementation in Overweight and Obese Class I Subjects with Newly Detected Impaired Fasting Glycemia: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Authors:  Mariangela Rondanelli; Antonella Riva; Giovanna Petrangolini; Pietro Allegrini; Luisa Bernardinelli; Teresa Fazia; Gabriella Peroni; Clara Gasparri; Mara Nichetti; Milena Anna Faliva; Maurizio Naso; Simone Perna
Journal:  Nutrients       Date:  2020-10-28       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.